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ABSTRACT
Signal Transducer and Activator of Transcription
3 (STAT3) is a transcription factor that plays a
crucial role in interleukin-6 (IL-6) signaling, medi-
ating the acute-phase induction of the human
Angiotensinogen (hAGT) gene in hepatocytes. We
showed earlier that IL-6 induces acetylation of the
STAT3 NH2-terminus by the recruitment of the p300
coactivator. We had also observed a physical inter-
action of STAT3 and Histone Deacetylase1 (HDAC1)
in an IL-6-dependent manner that leads to transcrip-
tional repression. In this study, we sought to eluci-
date the mechanism by which HDAC1 controls
STAT3 transcriptional activity. Here, we mapped
the interacting domains of both STAT3 and HDAC1
and found that the COOH-terminal domain of HDAC1
is necessary for IL-6-induced STAT3 transcriptional
repression, whereas the NH2-terminal acetylation
domain of STAT3 is required for HDAC1 binding.
Interestingly, over expression of HDAC1 in HepG2
cells leads to significantly reduced amounts of
nuclear STAT3 after IL-6 induction, whereas silenc-
ing of HDAC1 resulted in accumulation of total
and acetylated STAT3 in the nucleus. We have
found that HDAC1 knockdown also interferes with
the responsiveness of the STAT3-dependent MCP1
target gene expression to IL-6, as confirmed by real-
time RT–PCR analysis. Together, our study reveals
the novel functional consequences of IL-6-induced
STAT3-HDAC1 interaction on nucleocytoplasmic
distribution of STAT3.
INTRODUCTION
The signal transducers and activators of transcription
(STATs) are a family of latent cytoplasmic transcription
factors mediating target gene activation in response to
cytokines and growth factor stimulation (1,2). Seven
STAT family members (and their alternative splice pro-
ducts) have been identiﬁed, with each member being acti-
vated by a distinct spectrum of cytokines (3). Like other
STAT transcription factors, STAT3 is predominantly
cytoplasmic in resting cells, a feature which facilitates the
ability of STAT3 to directly transduce signals from cell
surface associated cytokine receptor to target genes in the
nucleus. In response to cytokine stimulation, STATs
become tyrosine phosphorylated at their COOH-terminus
by receptor and receptor-associated tyrosine kinases.
Activated STATs form homo- or heterodimers through
intermolecular src homology domain 2 (SH2)-phosphotyr-
osine interactions, disengage from the liganded receptor
and subsequently translocate into the nucleus where they
bind enhancer sequences [50-TT(N4-6)AA-30] of target
genes (4,5). Once the activated STAT dimer recognizes a
target promoter, the transcription rate from this promoter
is dramatically increased, reﬂecting the ability of STAT
transcriptional activation domains to recruit nuclear
coactivators that mediate chromatin decondensation and
communicate with proteins binding the core promoter.
Although phosphorylation is a crucial posttranslational
modiﬁcation that regulates the activities of diﬀerent
proteins, there are many others including methylation
(6), ubiquitination (7), sumoylation (8), isgylation (9) and
acetylation (10). Indeed, it has been found that diﬀerent
STAT 1 and 3 isoforms are inducibly acetylated, a modi-
ﬁcation yielding a variety of consequences for target gene
transcription. For example, we had recently shown that
IL-6-induced acetylation of STAT3 NH2-terminus is
required for recruitment of the p300 coactivator and is
necessary for target gene expression through a novel
mechanism involving acetylation/deacetylation (11,12).
We further showed that the STAT3 NH2-terminal acetyla-
tion is necessary for target gene transcription by stabilizing
the STAT3–p300 complex. Others have found that STAT3
dimerization is regulated by reversible acetylation of lysine
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acetylated by the CBP coactivator, a modiﬁcation that
regulates NF-kB activity leading to induction of apoptosis
(14). Together, these observations indicate that site-speciﬁc
acetylation of STAT3 is an important regulatory modiﬁca-
tion that inﬂuences protein–protein interaction.
Histone and non-histone protein acetylation is a revers-
ible reaction controlled by the steady state level of histone
acetyltransferases (HATs) and histone deacetylases
(HDACs). In humans, HDACs are divided into three cate-
gories: class I RPD3-like proteins (HDAC1, HDAC2,
HDAC3 and HDAC8); the class II HDA1-like proteins
(HDAC4, HDAC5, HDAC6, HDAC7, HDAC9 and
HDAC10); and the class III SIR2-like proteins (15,16).
Class I HDACs are ubiquitously expressed while the
expression of many class II HDACs are tissue-speciﬁc.
Recently class IV HDACs, a group consisting of HDA-
C11–related enzymes has also been described (17,18).
HDAC1, 2 and 8 are predominantly nuclear proteins
while HDAC 3, 4, 5, 7 and 9 shuttle between the nucleus
and cytoplasm (15).
The class I enzyme HDAC1 is a nuclear protein and can
heterodimerize with the closely related deacetylase
HDAC2 (19). Two important functional regions of
HDAC1 proteins have been identiﬁed in mouse (20):
the NH2-terminus contains a motif required for HDAC1
homo-oligomerization and for hetero-oligomerization of
HDAC1 with HDAC2 and HDAC3. The COOH-terminal
lysine rich sequence (amino acid residues 438–482), on
the other hand, is crucial for the nuclear localization of
HDAC1. Both HDAC1 and 2 are found in three
major multiprotein complexes, named Sin3, NuRD, and
CoREST (21,22). HDAC1 can repress gene transcription
either directly or as part of these multiprotein complexes
when recruited to the promoter by a variety of transcrip-
tional regulators (15,23). One emerging concept is that
acetylation–deacetylation reactions play a role in cellular
processes independent of transcription. For example,
acetylation regulates protein stability, protein–protein
interactions and nuclear localization (24). Acetylation
of HNF4 and E1A adenovirus-transforming protein, is
known to enhance nuclear retention by increasing nuclear
import and blocking nuclear export of these transcription
factors (25,26). Conversely, deacetylation of SRY, a Y
chromosome-encoded DNA-binding protein, by HDAC3
induces cytoplasmic delocalization of the protein from the
nuclear compartment (27). HDAC mediated deacetylation
of proteins, in many cases is known to be prerequisite
for subsequent ubiquitination and degradation (16,24).
In this studywe show for the ﬁrst time thatacetylation of
STAT3 and its subsequent binding with HDAC1 is
involved in control of its nucleocytoplasmic distribution.
We present evidence that the NH2-terminal domain of
STAT3 interacts with HDAC1, and that STAT3 acety-
lation is required for this interaction. Overexpression of
HDAC1 in HepG2 cells leads to signiﬁcantly reduced
amount of IL-6-induced nuclear STAT3, whereas
HDAC1 silencing through RNA interference results in
STAT3 accumulation in the nucleus. Consistent with this
ﬁnding, we have found that HDAC1 knockdown also
interferes with the responsiveness of the STAT3-dependent
reporter gene and target gene expression to IL-6 stimula-
tion. Together, these ﬁndingssuggest anovel mechanism of
how protein–protein interaction coupled with chemical
modiﬁcation regulate STAT3 transcription.
MATERIALS AND METHODS
Cellculture andreagents
Human hepatoblastoma HepG2 cells were obtained from
ATCC (Manassas, VA) and cultured as previously
described (28). Human colon carcinoma HCT 116 cells
(ATCC) were grown at 378Ci n5 %C O 2 in McCoy 5A
medium (Life Technologies, Inc.) supplemented with 10%
fetal bovine serum, penicillin (100U/ml) and streptomycin
(100mg/ml). Recombinant IL-6 was from Calbiochem
(San Diego, CA) (12). Human acute monocytic leukemia
THP-1 cells (ATCC) were cultured at 378Ci n5 %C O 2 in
RPMI medium 1640 with 25mM HEPES and 2mM
L-glutamine (GIBCO) supplemented with 10% fetal
bovine serum, penicillin (100U/ml), streptomycin
(100mg/ml), 4.5g/l glucose, and 1mM sodium pyruvate.
Plasmids and transfection
The WT STAT3, NH2- and COOH-terminal truncated
human STAT3 expression plasmids [amino acids (aa)
1–770, 130–770, 1–688, 1–585] were constructed by PCR
using wild type STAT3 as a template and gene-speciﬁc
primers (11). Plasmid V5-tagged STAT3 (aa 1–130) were
constructed using the primer pairs as follows: 50-G
GAAATGGCCCAATGGAATCAGCTACAG-30 and
50-GTTGGCCTGGCCCCCTTGCTG-30 and cloned into
pEF6/V5-His. STAT3 Lys-to-Arg mutations at residues
49 and 87 were performed by PCR synthesis by overlap
extension using STAT3 WT cDNA as a template and with
the mutagenic primer pairs (11).
FLAG-tagged STAT3 WT (1–124), STAT3 K49/87Q
(1–124) and STAT3 K49/87R (1–124) were made in
pECFP-Nuc by PCR reaction using full length template
STAT3 WT, STAT3K49/87Q, STAT3 K49/87R in
pEF6-V5, respectively. The primer pairs used were: sense
primer 50 CATCGATGGATCCATGGACTACAAAG
ACGATG ACGATAAGGCCCAATGGAATCAGCTA
CAG 30 and antisense primer 50 CGTACCTCTAGACT
ACTGGGCCGCAGTGGCTGCAGTCTG 30.
Fusion protein Gal4-STAT3(1–770) and UAS-LUC
reporter were previously described (12).
FLAG- tagged wild-type HDAC class I expression vec-
tors and reporter plasmids (hAPRE1)5-LUC were pre-
viously described (11,28). FLAG-tagged HDAC1
deletion mutants (aa 1–482, 1–140 and 141–482) were con-
structed in pcDNA3 FLAG expression plasmid using the
primer pairs as follows: For HDAC1 (aa 1–482),
50-TGCTCAGGATCCGCGCAGACGCAGGGCACCC
GG-30 and 50-GCTACTAAGCTTTCAGGCCAACTTG
ACCTCCTC-30 were used, for HDAC1 (aa 1–140),
50-TGCTCAGGATCCGCGCAGACGCAGGGCACCC
GG-30 and 50-GCTACTAAGCTTTCACAGGCCCCCA
GCCCAATT-30 were used and for HDAC1 (aa 141–482),
50-TGCTCAGGATCCCACCATGCAAAGAAGTCCG
Nucleic Acids Research, 2008, Vol. 36, No. 13 4511AG-30 and 50- GCTACTAAGCTTTCAGGCCAACTTG
ACCTCCTC-30 were used.
Transient transfections in exponentially growing HepG2
were performed using Lipofectamine PLUS reagent
(Life Technologies, Inc.). One microgram of indicated pro-
moter reporter was cotransfected with the transfection eﬃ-
ciency control plasmid pSV2PAP, and indicated expression
plasmids into 6-well plates (2.5 10
5 cells). Twelve hours
later, cells were stimulated with IL-6 (8ng/ml, 24h) before
harvest and luciferase assay and alkaline phosphatase
activity were measured. All transfections were carried out
in triplicate plates in three independent experiments.
siRNA transfection
Control and HDAC1 siRNA (Dharmacon Smart Pools)
were transfected into HepG2 cells by TransIT-siQUEST
transfection reagent (Mirus, Madison, WI) at 50nmol/l
ﬁnal concentration, following the manufacturer’s instruc-
tion. After 48–72h, cells were stimulated with IL-6 for
diﬀerent time periods as indicated.
Antibodies and immunoprecipitation
Sources of primary antibody (Ab) included Santa Cruz
Biotechnology for anti-STAT3 (K15 and C20) and anti-
phospho-Tyr STAT3 (B7); New England Bio Labs for
anti-HDAC1 Ab; anti-V5 and anti-FLAG Ab were
obtained from Invitrogen and Sigma respectively. Anti-
acetyl K87STAT3 Ab was generated and aﬃnity puriﬁed
as described earlier (11).
For immunoprecipitation and Western blot analysis,
either whole cell extracts (WCEs) or Nuclear Extracts
(NEs) were used as indicated. WCEs were prepared by
lysing HepG2 cells in modiﬁed RIPA buﬀer (50mM
Tris–HCl, pH 7.4, 150mM NaCl, 1mM EDTA, 0.25%
sodium deoxycholate, 1% Nonidet P-40, 1mM PMSF,
1mM NaF, 1mM Na3VO4, and 1mg/ml each of aprotinin,
leupeptin, and pepstatin). Sucrose cushion-puriﬁed NEs
were prepared by lysing HepG2 cells with nonionic deter-
gent (0.5% IGEPAL-60) and centrifugation over a sucrose
cushion as described (28). Extracts were precleared with
protein A-Sepharose 4B (Sigma) for 10min at 48C and the
cleared lysate incubated with primary Ab for 2–12h at
48C. Immune complexes were captured by adding 30ml
of protein A-Sepharose beads (50% slurry) and rotated
for 1h at 48C. Beads were washed three times for 5min
with cold PBS, immune complexes eluted by incubation in
SDS–PAGE loading buﬀer and fractionated by 10%
SDS–PAGE. Proteins were transferred to polyvinylidine
diﬂuoride membranes (Millipore, Bedford, Mass.) and
blocked with 5% milk for 1h followed by primary anti-
body treatment for overnight at 48C. Membranes were
washed in TBST (0.1%) tween and incubated with second-
ary antibody for 1h. Signals were detected by the
enhanced chemiluminescence assay (ECL, Amersham) or
visualized by the Odyssey Infrared Imaging system
(LICOR Biosciences, Lincoln, NE).
Real-timeRT–PCR analysis
Total cellular RNA was extracted by Tri Reagent (Sigma).
One microgram of RNA was used for reverse transcription
using iScript cDNA Synthesis Kit (Bio Rad). Three micro-
liters of cDNA products was ampliﬁed in 20ml reac-
tion system containing 10ml iQ SYBR Green Super Mix
(Bio Rad) and 400nM primer mix. All the primers
were designed by Primer Express version 2.0 software.
For Human MCP-1 mRNA expression, forward primer
50-CATTGTGGCCAAGGAGATCTG-30 and reverse
primer 50-CTTCGGAGTTTGGGTTTGCTT-30 were
used. All reactions were processed in MyiQ Single-Color
Real-Time PCR Detection System (Bio Rad) and results
were analyzed by IQ5 program (Bio Rad). To normalize
template input, GAPDH (endogenous control) transcript
level was measured for each sample. Data are expressed
as fold change relative to unstimulated, after normalizing
to GAPDH.
Immunofluorescence staining
Cells were acetone-methanol ﬁxed, rinsed in PBS contain-
ing 50mM NH4Cl for 10min, and permeabilized in PBS
containing 0.1% Triton X-100. Cells were then blocked
with pre-immune heterologous serum (diluted 1:10 in
PBS) for 30min, washed, and incubated with primary
and secondary (FITC and Rhodamine (Rd)-conjugated)
Ab. After staining, cells were mounted in antifading
mounting solution (DAKO Inc. Carpentaria, CA).
Confocal microscopy was performed on a Zeiss LSM510
META System using the 488nm line of the Argon-laser
for excitation of FITC and Helium-Neon 543nm line for
excitation of Rd, combined with appropriate dichroic mir-
rors and emission band ﬁlters to discriminate between
green and red ﬂuorescence. Images were captured at a
magniﬁcation of  60 (60  oil immersion objective numer-
ical aperture 1.4). Co-localization was visualized by super-
imposition of green and red images using MetaMorph
software Version 4.6r9 (Universal Imaging Corp).
In vitro deacetylation assay
Wild type (aa 1–770) and NH2-terminal deleted
(aa 130–770) V5-tagged STAT3 plasmids were expressed
in HepG2 cells and in vitro deacetylation assay
(UPSTATE Biochemicals) was performed following the
protocol as recommended by the supplier.
RESULTS
HDAC1 interferes with STAT3-dependent transactivation
Earlier we showed by nondenaturing coimmunoprecipi-
tation assay that STAT3 binds HDAC1 in an IL-6-depen-
dent manner and interferes with hAGT expression (11).
To gain further insights into how IL-6-induced STAT3–
HDAC1 interaction could control target gene repression,
we examined the eﬀect of increasing doses of ectopically
expressed HDAC1 on IL-6 inducible transcription using a
high aﬃnity STAT3-binding site termed (hAPRE1)5-LUC
reporter plasmid, in HepG2 cells (28). Relative to empty
vector control, cells transfected with HDAC1 showed sig-
niﬁcant inhibition of IL-6-mediated hAGT promoter activ-
ity in a dose-dependent manner (Figure 1A). A signiﬁcant
reduction of promoter activity was seen with transfection
4512 Nucleic Acids Research, 2008, Vol. 36, No. 13of only 0.2mg of HDAC1 expression plasmid and a >90%
reduction with 0.8mg. This conﬁrms our previous observa-
tion of the inhibitory eﬀect of HDACs in IL-6-induced
transactivation (11).
To further conﬁrm that HDAC1 inhibits STAT3
mediated transactivation, we ﬁrst assayed whether
Gal4-STAT3 (1–770) could transactivate Gal4-binding
sites (UAS-LUC) in HepG2 cells (Figure 1B). We observed
that a 4.6-fold increase in UAS-LUC promoter activity
mediated by Gal4-STAT3 (1–770), is completely inhibited
by ectopic HDAC1 expression (although HDAC1
alone has no eﬀect on UAS-LUC, data not shown),
indicating the role of HDAC1 as a repressor in STAT3
transactivation (11).
The COOH-terminal domain ofHDAC1 is required
fortarget generepression
To identify the domains required for transcriptional inhi-
bition, FLAG epitope-tagged HDAC1 deletion mutants
were expressed and eﬀects were tested on STAT3-depen-
dent transcription. For this purpose, HepG2 cells were
cotransfected with (hAPRE1)5-LUC reporter plasmid
and expression plasmids encoding either with FLAG-
tagged HDAC1 full length (FL, aa 1–482) or the
HDAC1 NH2-terminal regulatory domain (C, aa
1–140) or the HDAC1 carboxy-terminal domain (N,
aa 141–482). In absence of HDAC1, IL-6 strongly induced
(hAPRE1)5-LUC reporter activity by 8-fold (Figure 2A).
Cotransfection of HDAC1 full length strongly inhibited
both basal and IL-6-induced reporter activity. By con-
trast, the HDAC1 NH2-terminal regulatory domain had
little eﬀect. Expression of the HDAC1 COOH-terminal
decaetylase and phosphorylation domain showed a
strong inhibitory eﬀect on STAT3 dependent transcrip-
tion. This result suggested to us that the histone deacety-
lation activity of HDAC1 is closely linked to its
transcriptional repression activity.
We next performed coimmunoprecipitation studies to
localize the domains of HDAC1 that bind to endogenous
STAT3. FLAG-epitope tagged HDAC1 FL (aa 1–482),
HDAC1 C (aa 1–140) and HDAC1 N (aa 141–482)
were transfected in HCT 116 cells and IL-6 stimulated
WCEs were immunoprecipitated with anti-FLAG conju-
gated agarose beads. Western immunoblot analysis with
anti-STAT3 antibody shows that both NH2-terminal
domain and COOH-terminal domain of HDAC1 bind to
endogenous STAT3, although these domains had diﬀeren-
tial repression eﬀect on STAT3 transcription (Figure 2B).
HDAC1binds to theNH2-terminus ofSTAT3
To map the STAT3 domains involved in HDAC1 complex
formation, we transfected HepG2 cells with diﬀerent
V5-tagged deletion mutants of STAT3 (aa 1–770, aa
1–688, aa 1–585, aa 1–130 and aa 130–770). Whole cell
extracts were isolated and subjected to non denaturing
immunoprecipitation with anti-V5 Ab. After SDS-PAGE
fractionation, Western immunoblots were done with anti-
HDAC1 Ab to detect associated endogenous HDAC1.
Full-length STAT3 (aa 1–770) and the COOH-terminal
deletion mutants (aa 1–130), (aa 1–585), (aa 1–688), all
bind endogenous HDAC1 whereas the STAT3 NH2 term-
inal deletion mutant (aa 130–770) failed to bind
(Figure 2C). This ﬁnding suggested that the NH2-terminal
domain of STAT3 was necessary and suﬃcient for
HDAC1 interaction.
NH2-terminal acetylation of STAT3 isnecessary
forHDAC1 binding
Next, we tested the requirement of STAT3 NH2-terminal
acetylationforits invivointeractionwithHDAC1bytrans-
fecting HepG2 cells with a full-length STAT3 acetyl-
deﬁcient mutant (STAT3 K49R/K87R). Figure 2C, lane 6
Figure 1. (A) Dose-dependent inhibition of IL-6-mediated target gene
expression by histone deacetylase 1 (HDAC1). HepG2 cells were tran-
siently transfected with (hAPRE1)5-LUC reporter plasmid, pSV2-PAP
internal control, and indicated amounts of HDAC1 expression vectors
(200, 400, 600 and 800ng, respectively). Twenty four hours after trans-
fection, cells were stimulated with IL-6 (8ng/ml). Luciferase activity
was measured after 24h of stimulation and normalized to alkaline
phosphatase activity. Amount of transfected DNA was kept equivalent
using an empty expression plasmid.
 P<0.05 relative to empty vector,
t-test. Ectopic expression of FLAG-tagged HDAC1 in transient trans-
fection is shown by Western blot (inset). (B) Transrepression of STAT3
with HDAC1. HepG2 cells were transfected with UAS-LUC and either
Gal4-STAT3 (full length, 1–770) expression plasmid or Gal4- STAT3
and HDAC1 together and stimulated with IL-6. HDAC1 repressed
transactivation of UAS-LUC by GAL4- STAT3. Luciferase activity
was measured after 24h of IL-6 stimulation and normalized to alkaline
phosphatase activity.
 P<0.05 relative to empty vector, t-test.
Nucleic Acids Research, 2008, Vol. 36, No. 13 4513Figure 2. (A) HDAC1 COOH-terminal domain is required for IL-6 induced repression of target gene. Schematic diagram of HDAC1 domains
(top panel). Amino acid residues (1–139) represents NH2-terminal domain, aa residues (140–208) represents catalytic domain and aa residues
(209–482) represents COOH-terminal domain. HepG2 cells were transfected with (hAPRE1)5-LUC reporter plasmid and either with HDAC1 full-
length expression vector (FL, aa 1–482), or COOH-terminal deleted HDAC1 (C aa 1–140) or NH2-terminal deleted HDAC1 (N aa 141–482)
expression vectors were transfected (bottom panel). Twenty four hours after transfection cells were simulated with IL-6. Luciferase activity was measured
after 24h.
 P<0.05 relative to empty vector, t-test. (B) HDAC1 deleted mutants (C and N) binds to STAT3. HCT 116 cells were transfected with
FLAG-tagged HDAC1 FL, or HDAC1 N or HDAC1 C deletion mutants. IL-6 stimulated WCEs were immmunoprecipitated with anti-FLAG
conjugated agarose Ab followed by Western immunoblot with anti-STAT3 Ab (lower panel), UC represents untransfected control lane. Upper panel
shows the expression of FLAG-tagged HDAC1 mutants. (C) Mapping of HDAC1-binding site on STAT3. Top panel shows the schematic diagram of
STAT3 domains. HCT 116 cells were transfected with either full-length STAT3-V5 expression vector, (aa 1–770) or with diﬀerent deletion mutants of
STAT3 (aa 130–770, 1–130, 1–585, 1–688) or with acetylation-deﬁcient STAT3 mutant (STAT3K49R/K87R). IL-6 stimulated WCEs were immunopre-
cipitated with anti-V5 Ab and Western immunoblots were performed with anti-HDAC1 Ab (upper panel). Lower panel shows expression of diﬀerent
V5-tagged STAT3 mutants.
 P<0.05 relative to empty vector, t-test. (D) Association of FLAG-tagged WT/KQ/KR STAT3 (1–124) with endogenous
HDAC1. HCT 116 cells were transfected with FLAG-tagged STAT3 WT (1–124), STAT3 K49/87Q (1–124) and STAT3 K49/87R (1–124). WCE were
immunoprecipitaed with FLAG-agarose conjugate and immune-complexes were detected with anti-HDAC1 antibody. Lower bar diagram shows the
quantitation of bands (from upper panel) that indicate immunoprecipitated HDAC1. IB represents immune blot. EV represents empty vector.
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requires acetylation of STAT3 since STAT3 K49R/K87R
apparently weakly binds to endogenous HDAC1.
However, because the expression of STAT3 K49R/K87R
were reduced relative to thoseof wild type (WT) STAT3 we
conducted further experiments with FLAG epitoped
tagged NH2 terminal domain of STAT3, where the level
of expression was comparable. For this experiment,
FLAG-WT STAT3 (1–124), pseudoacetylated STAT3
(K49/87Q) (1–124) and acetyl deﬁcient STAT3 (K49/
87R) (1–124) were transfected and complexes were immu-
noprecipitatedwithanti-FLAGagarosebeads(Figure2D).
We noted that endogenous HDAC1 bound with the
WT- and pseudoacetylated STAT3, whereas the acetyl
mutant STAT3 bound very weakly.
Next, we performed confocal immunohistochemistry to
study colocalization of WT STAT3 and NH2-terminal
deleted STAT3 (130–770) with endogenous HDAC1.
Expression vectors encoding WT-STAT3 and STAT3
(130–770) were transfected in HepG2 cells and stimulated
with IL-6. Both HDAC1 (red) and STAT3 (green) were
distributed throughout the nucleus and are excluded from
the nucleoli (Figure 3A). The merged image showed that
WT STAT3 colocalized with endogenous HDAC1,
whereas the NH2-terminal deleted STAT3 mutant
poorly localized, further conﬁrming requirement of the
NH2-terminal STAT3 in HDAC1 binding. Together,
these results indicate that NH2-terminal domain of
STAT3 as well as its acetylation is necessary for stable
complex formation with HDAC1.
We next sought to determine whether the STAT3–
HDAC1 complex is associated with HDAC activity. For
this purpose, we developed an immunoprecipitation-
in vitro deacetylation assay. Wild type (aa 1–770)
V5-tagged STAT3 and NH2-terminal deleted STAT3
(aa 130–770) were cotransfected with HDAC1 expression
vector and IL-6 stimulated HepG2 WCEs were immuno-
precipitated with V5 antibody. The washed immune com-
plexes were then incubated in vitro with [
3H]-labeled
histone H4 (aa 2–24) peptide and deacetylation activity
was measured by [
3H] release. We observed strong his-
tone deacetylase activity in the immunoprecipitated
V5-tagged full length STAT3 complexes from IL-6 stimu-
lated HepG2 cells. Most strikingly, the 130 aa NH2-
terminal deletion of STAT3 (130–770), a mutation that
does not bind HDAC1 (Figures 2C, 2D and 3A),
showed very little HDAC activity. This data further
indicated that the STAT3 NH2-terminus is essential
for the functional recruitment of histone deacetylases
(Figure 3B).
HDAC1 controls nuclear STAT3 abundance
To verify the role of HDAC1 in STAT3 transcriptional
activity, IL-6 responses were evaluated in cells where
HDAC1 expression level was either enhanced or reduced.
For this, HepG2 cells were transfected with HDAC1
expression vector or empty vector as control and stimu-
lated with IL-6 for 0, 20, 60 and 90min. Nuclear and
cytoplasmic distribution of endogenous STAT3 protein
was then determined by Western immunoblot analysis
with anti-STAT3 Ab (Figure 4). In empty vector trans-
fected cells, IL-6 induced a rapid accumulation of
STAT3 within 20min of stimulation, concomitant with
the nuclear appearance of phospho-Tyr
705 STAT3. In con-
trast, HDAC1 overexpression reduced nuclear STAT3
(total) abundance after IL-6 stimulation compared to
empty vector control although the phospho-Tyr
705
STAT3 level remained the same. Because HDAC1
reduced the nuclear accumulation of STAT3 and
enhanced its cytoplasmic abundance, these data suggested
to us that HDAC1 is involved in STAT3 nucleocyto-
plasmic partitioning.
Figure 3. (A) Localization of STAT3 with HDAC1. HepG2 cells were
transfected with either V5-tagged WT STAT3 (1–770) (upper panel) or
NH2-terminal deleted STAT3 (130–770) (lower panel) and stimulated
with IL-6 for 30min. Cells were ﬁxed and incubated with anti-V5 Ab
and antibody to HDAC1. Binding of primary antibody was detected by
FITC- or Texas red-labeled secondary antibody. Confocal microscopy
was performed on a Zeiss LSM510 META System using the 488nm
and 543nm excitation for FITC and Texas red, respectively. Images
were captured at a magniﬁcation of  60. Co-localization was visualized
(in the right panel, merge) by superimposition of green and red images
using MetaMorph software. (B) Histone deacetylase activity is asso-
ciated with STAT3 immune complex. HepG2 cells were transfected
with either control empty vector, or full-length V5-tagged STAT3 or
STAT3 NH2-terminal deleted mutant (aa 130–770) that weakly binds
HDAC1. IL-6 stimulated WCEs were immunoprecipitated with anti-V5
Ab and these immune complexes were used for in vitro deacetylation
assay to decaetylate [
3H]-labeled histone H4 peptide (substrate),
as described in the deacetylation assay kit protocol (UPSTATE
Biochemicals).
 P<0.05 relative to empty vector control extract, t-test.
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To further prove the involvement of HDAC1 in STAT3
nucleocytoplasmic distribution, the eﬀect of reducing
endogenous HDAC1 level was investigated. For this pur-
pose, RNA interference was used to reduce HDAC1
expression in HepG2 cells, where HDAC1 levels were
reduced by more than 70%, compared to control siRNA
(Figure 5A). IL-6-dependent nuclear translocation of
STAT3 was then determined by Western immunoblot
analysis after HDAC1 knockdown. HepG2 cells were
transfected with either control siRNA or HDAC1 speciﬁc
siRNA and IL-6 stimulated prior to NE preparation.
Western blots of NEs were probed with either anti-
STAT3 Ab, or anti- phospho-STAT3 Ab or with anti-
acetyl K87 STAT3 Abs (11). Figure 5B indicates that, in
the presence of control siRNA, STAT3 is eﬃciently trans-
located from cytoplasm into the nucleus. In presence of
HDAC1 siRNA, both the total STAT3 and acetylated
STAT3 accumulated in the nucleus even in the absence
of stimulation. Interestingly, we did not observe any
change in abundance of phospho-Tyr
705 STAT3 in the
nucleus in the presence of HDAC1 siRNA. This above
result of nuclear retention along with that from the
HDAC1 overexpression study (Figure 4) strongly
implicate that HDAC1 plays an important role in nucleo-
cytoplasmic partitioning of STAT3.
SubcellularlocalizationofSTAT3afterHDAC1knockdown
We next assessed the dynamics of cytoplasmic-nuclear
translocation of STAT3 by confocal microscopic imaging
on HepG2 cells transfected either with control siRNA or
with HDAC1 siRNA, in presence or absence of IL-6. In
control siRNA-treated unstimulated cells, the majority of
STAT3 was detected in the cytoplasm (Figure 6).
Treatment of cells with IL-6 for 30min altered the equilib-
rium between the nuclear and cytoplasmic STAT3 and
induced a complete nuclear translocation of STAT3 and
which again redistributed back into the cytoplasm after
90min of stimulation. Similarly, with HDAC1 siRNA
treatment, although we observed some basal level of
STAT3 in the nucleus and in the perinuclear region of
the resting cells, STAT3 rapidly translocated in the
nucleus from cytoplasmic compartment after 30min of
IL-6 stimulation, and it remained accumulated in the
nucleus even after 90min of IL-6 treatment, a time when
STAT3 normally exported back into the cytoplasm (upper
panel). This data further supports our above conclusion
that HDAC1 is involved in STAT3 nucleocytoplasmic
partitioning.
HDAC1 knockdowninterferes withthe responsiveness of
STAT3-dependent target geneactivation
To determine HDAC1’s role in IL-6 inducible transcrip-
tion, cells transfected with HDAC1 siRNA were subse-
quently re-transfected with STAT3-dependent
(hAPRE1)5-LUC reporter. As seen in Figure 7A, IL-6
treatment increased STAT3 dependent (hAPRE1)5-LUC
luciferase activity by 10–12-fold in control siRNA
Figure 4. Rapid nuclear export of endogenous STAT3 after HDAC1
overexpression. HepG2 cells were transfected with either empty vector
or HDAC1 expression vector. Twenty-four hours after transfection,
cells were stimulated with IL-6 for indicated times. NEs (top panel)
and CEs (bottom panel) were separated by SDS–PAGE and Western
immunoblot analysis were performed with anti-STAT3 Ab and anti-
phospho-Tyr
705 STAT3 Ab (NE only). Lamin B and b Actin Abs were
used as nuclear and cytoplasmic marker, respectively.
Figure 5. (A) HDAC1 knockdown in HepG2 cells by speciﬁc siRNA.
HepG2 cells were transfected with indicated amounts of control and
HDAC1 siRNA (Smart Pool from Dharmacon Inc.). WCEs were iso-
lated 72h after transfection and Western immunoblots were performed
with anti-HDAC1 Ab (upper panel). Lower panel shows expression of
b Actin as internal control. (B) HDAC1 knockdown accumulates
STAT3 in the nucleus. HepG2 cells were transfected with either control
siRNA or HDAC1 siRNA for 72h. IL-6 stimulated (20min) NEs were
prepared and separated by SDS–PAGE followed by Western immuno-
blot analysis with anti-STAT3 Ab, anti-AcLys87 STAT3 Ab, or anti-
phospho-Tyr
705 Ab. Lower panel shows expression of HDAC1 after
HDAC1 siRNA knockdown. Band intensity were plotted and shown
in right-hand side panel.
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ever, IL-6 inducible reporter activity was further increased
to 30-fold, indicating that endogenous HDAC1 levels nor-
mally repress IL-6-inducible transcription. We interpret
these data to mean that the eﬀect of HDAC1 knockdown
on hAGT reporter is due to reduced nuclear export, lead-
ing to nuclear accumulation of acetyl STAT3 and
enhanced target gene transcription.
Next, to determine whether the eﬀect of HDAC1 on
STAT3 transcription is cell type-speciﬁc or global phe-
nomena, we measure more quantitatively the eﬀect of
HDAC1 knockdown on IL-6-inducible STAT3 target
gene by real-time RT–PCR analysis. For this purpose
we used human acute monocytic leukemia THP-1 cells
(29) to measure the abundance of Monocyte
Chemotactic Protein-1 (MCP1) mRNA after IL-6 induc-
tion for diﬀerent time periods. MCP1 is known to be an
IL-6-induced STAT3 downstream target gene and is
expressed in human promonocytic cell lines (30). In con-
trast to control siRNA, the induction of MCP1 mRNA
after HDAC1 knockdown was signiﬁcantly increased after
24h and 40h of IL-6 treatment (Figure 7B).
From these results, we concluded that HDAC1 is
required for the termination of IL-6-dependent trans-
cription by STAT3 and subsequent redistribution from
the nucleus.
DISCUSSION
STAT3 is the central mediator of IL-6-induced gene
expression which is phosphorylated at Tyr
705 by the recep-
tor associated Janus kinases, an essential prerequisite for
dimerization and nuclear translocation (1,3). In addition,
an acetylation/deacetylation cascade of STAT3 has been
recently identiﬁed (11,13), which is essential for its
enhanced transcriptional competence. The duration and
degree of gene activation in response to cytokine signals
is primarily dictated by the subcellular distribution and
nucleocytoplasmic shuttling of STAT3. STAT3 is predom-
inately cyotplasmic in unstimulated resting cells. Upon
cytokine stimulation, it quickly translocates to the
nucleus, where it mediates the induction of immediate
early genes. To control transient signal transmission by
activated STAT3, re-export of STAT3 back to the cyto-
plasm is also regulated. Thus nuclear export of STAT3
serves to prepare the cells for its next round of signaling.
Figure 6. Accumulation of nuclear STAT3 after HDAC1 knockdown.
HepG2 cells were transfected with either control siRNA or HDAC1
siRNA. Seventy-two hours later cells were stimulated with IL-6 for
indicated time. Cells were ﬁxed and stained with either ﬂuorescein
isothiocyanate (FITC)-anti-STAT3 Ab. Staining with FITC-anti-
AcK87 STAT3 Ab (data not shown) had similar result. Nuclei were
stained with DAPI. Confocal immunoﬂuorescence of representative
cells is shown. Figure 7. (A) HDAC1 knockdown activates IL-6 stimulated hAGT pro-
moter activity in HepG2 cells. HepG2 cells were transfected with either
control siRNA or HDAC1 siRNA along with (hAPRE1)5-LUC reporter.
Forty-eight hours after transfection cells were stimulated with IL-6 for
24h and then harvested for luciferase reporter assay.
 P<0.05 relative to
control siRNA, t-test. (B) Silencing of HDAC1 activates IL-6 regulated
MCP1 expression in human monocytic THP1 cells. THP1 cells were
transfected with either control siRNA or HDAC1 siRNA. Thirty-six
hours after transfection, cells were stimulated with IL-6 for indicated
time and total RNA was extracted at the same time for real-time
RT–PCR analysis.
 P<0.05 relative to control siRNA, t-test.
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STAT3 upon cytokine stimulation is known (2,3), the
mechanism by which activated STAT3 export from the
nucleus is not well deﬁned. Previous studies have shown
that nuclear STAT3 is regulated by two distinct export
of pathways controlled by three distinct nuclear export
signal (NES) elements with various potencies, located at
residues 306–318 (NES1), 404–414 (NES2), and 524–535
(NES3) (31). Among these, NES1 and NES2 are con-
served with STAT1, whereas NES3 being unique to the
STAT3 isoform. NES1 appears to be important for rapid
post stimulation nuclear export, whereas NES2 and NES3
play important roles in controlling the basal nuclear
export pathways.
Acetylation of histones and non-histone proteins are
reversed by a large number of HDACs, which are ubiqui-
tous in eukaryotic cells. Human HDAC1 and HDAC2
exist together in at least three distinct multi-protein
co-repressors complexes called the Sin3, NURD/Mi2,
and CoREST complexes (21,22). Many known transcrip-
tional repressors such as YY1 and RB associate and recruit
the HDAC1/HDAC2 and mSin3A corepressor complexes
to target gene promoters, thereby repressing transcrip-
tion (22). Although, majority of HDAC1 target genes
showed reduced expression accompanied by recruitment
of HDAC1 and local reduction in histone acetylation at
regulatory regions, a small subset of HDAC1 target genes
(Gja1, Irf1 and Gbp1) were also found that require
HDAC1 activity and recruitment for their transcriptional
activation (32). This regulation occurs either by direct
recruitment of HDAC1 to the promoter or by indirect
deacetylation of acetylated transcription factors thereby
modulating their activity. Recently, posttranslationaly
modiﬁed HDAC1 was found to associate with hormone-
activated glucocorticiod receptor (GR) (33). Here, hor-
mone activation of GR leads to progressive acetylation
of HDAC1, an event that inhibits the deacetylase activity
of the enzyme required for promoter activation.
In contrast to our observation where HDAC1 acts as a
repressor for IL-6-mediated STAT3 transactivation, it has
also been demonstrated that the deacetylase activity of
HDAC1 (and also 2 and 3) is required for STAT1 depen-
dent gene activation (34,35). Treatment of HDAC inhibi-
tors (HDACi), or silencing of HDAC1, 2 and 3 negatively
regulate STAT1-dependent transcriptional activation.
These ﬁndings suggest that hyperacetylation of histones
may negatively regulate STAT1-dependent gene activa-
tion. Consistent with these ﬁndings, it has been recently
demonstrated that STAT1 undergoes acetylation upon
HDACi treatment in human melanoma cell lines, which
alters its interaction with HDACs, CBP and NF-kB.
Acetylated STAT1 can only interact with NF-kB p65
and inhibits its DNA binding, nuclear localization and
hence expression of anti-apoptotic genes (14).
In this study, we provide the ﬁrst evidence for the
involvement of HDAC1 on nucleocytoplasmic distribution
ofSTAT3.Wehavealsodelineatedamolecularmechanism
by which STAT3 acetylation-mediated HDAC1 interac-
tion controls partitioning of STAT3. Our earlier studies
showed that IL-6-dependent acetylation of two Lys resi-
dues (Lys
49 and Lys
87) in the STAT3 NH2-terminus
plays a critical role in transactivation of the human AGT
gene (11). We also showed that HDAC1 stably interacts
with STAT3 in IL-6-dependent manner and downregulates
hAGT transactivation. In this study, we found that the
NH2-terminal domain (aa residues 1–130) of STAT3 is
required for HDAC1 binding and acetylation of this
domain at Lys
49 and Lys
87 are necessary for HDAC1 inter-
action. It is interesting to note that the NH2-terminus of
STAT3 is an independently folded modular domain that is
highly conserved across the various STAT family members
(36). The NH2-terminus is thought to play an important
role in DNA-binding and protein–protein interaction. For
example, NH2-terminus of both STAT1 and STAT3 have
been shown to interact with the p300 acetyltransferase
(13,37). In our previous study we have found that NH2-
terminal acetylation of STAT3 is also required for its
stable interaction with p300 (11). This evidence indicates
that the HDAC1 deacetylase and the p300 acetylase
interact with STAT3 in the same NH2-terminal region
(aa 1–130). Together, we suggest that HDAC1 negatively
regulates STAT3 transcription not only by its catalytic
activity indirectly, but also inhibiting interaction with
p300 and playing a key role in STAT3 transcription.
We showed earlier that the acetylation deﬁcient STAT3
mutant also has a qualitative defect in cytoplasmic redis-
tribution (11). This raised the possibility that acetylation
of STAT3 may controls its nucleocytoplasmic distribu-
tion. In this present study, our observation of acetyla-
tion-deﬁcient mutant STAT3 had reduced binding with
HDAC1 can explain our previous observation why the
STAT3 acetyl mutant had delayed nuclear export.
Three diﬀerent assays were used to investigate the role of
HDAC1 in the nucleocytoplasmic partitioning of STAT3.
First, over expression of HDAC1 in HepG2 cells, followed
by IL6-stimulation, resulted in a rapid nuclear export and
hence less nuclear STAT3 abundance. Whereas in empty
vector transfection, STAT3 eﬃciently translocates into the
nucleus within 20min of IL-6 stimulation and starts to
redistribute back into the nucleus in 60–90min, the kinetics
that are markedly accelerated with overexpressed HDAC1.
Second, siRNA mediated knock down of endogenous
HDAC1 prolonged STAT3 nuclear translocation. Here
we found accumulation of total and AcSTAT3 in unstimu-
lated NE (because of constitutive shuttling) and this
level remained the same even after IL-6 stimulation.
Interestingly, we did not observe any accumulation of
phospho-Tyr
705 STAT3 in the nucleus of unstimulated
cells indicating that dephosphorylated and acetylated
STAT3 accumulated in the nucleus of resting cells in
presence of HDAC1 siRNA. Although dephosphorylation
of Tyr
705 of STAT3 was proposed to be involved in nuclear
export to a certain extent (38,39), our observation that
HDAC1 overexpression/knockdown does not change the
phosphorylated form of STAT3 in the nucleus, indicates
that HDAC1 is not involved in the dephosphorylation of
STAT3. Third, immunoﬂuoresence studies with HDAC1
knockdown cells showed a slightly increased basal amount
of STAT3 in the nucleus of unstimulated cells which
increased upon IL-6 stimulation (30min). Importantly,
there was a delayed re-export of nuclear STAT3 after
90min of IL-6 stimulation. These data further support
4518 Nucleic Acids Research, 2008, Vol. 36, No. 13our conclusion that HDAC1 is required for STAT3
distribution.
STATs are nucleocytoplasmic shuttling proteins that
uses of both carrier-independent and carrier-mediated
translocation mechanism (40). The exportin CRM1 sup-
ports nuclear export of STATs to a minor extent (39,40).
Functional studies with GFP-tagged STAT3 and pre-
viously identiﬁed NESs by Bhattacharya et al. indicated
that these elements (NES1, 2 and 3) direct a bonaﬁde
CRM1-dependent nuclear export. The crystal structure
of STAT3 bound to DNA indicated that the NES2
(404–414) and NES3 (524–535) is either buried or partially
exposed. It is likely that these elements will only regulate
export after the STAT complex is dissociated from DNA
or binding of others factors that aﬀect the conformation of
the protein. Thus it appears likely that structural changes
associated with binding of HDAC1 to AcSTAT3 may play
an important role in binding of CRM1 with nuclear export
signal (NES) (31). Alternatively, it is possible that after
transactivation, AcSTAT3 binds with HDAC1 for deace-
tylation that enhances its interaction with nuclear exporter
CRM1 or with other HDACs (HDAC3 or other type II
HDACs that can shuttle between cytoplasm to nucleus
(41,42). However, it is interesting to note that acetylation
sites of STAT3 are not located in either of these NESes.
Therefore, how the AcSTAT3–HDAC1 association
couples with the rapid post-stimulation nuclear export
pathway will require further investigation.
In conclusion, we provide evidence that HDAC1 regu-
lates STAT3 nucleocytoplasmic distribution at least in
part by binding with acetylated STAT3 in IL-6-dependent
manner. Because STAT3 is of pathological importance,
and HDAC inhibitors are emerging as promising thera-
peutic agent against numerous diseases, their ability to
modify cytokine-dependent transcriptional regulation is
an important clinical consideration that might guide the
development of second generation deacetylase inhibitors.
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